---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-21-009802"
form_type: "8-K"
ticker: "TCMD"
cik: "0001027838"
company_name: "TACTILE SYSTEMS TECHNOLOGY INC"
filed_at: "2021-08-02T23:59:59+00:00"
generated_at: "2026-06-29T23:43:50.889629+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Tactile Medical Q2 revenue up 45% to $51.1M, net income $1.3M; raises FY guidance low end

## Summary
- Q2 revenue $51.1M (+45% YoY); net income $1.3M vs loss of $13.9M; diluted EPS $0.07 vs loss of $0.72.
- Adjusted EBITDA $4.1M vs loss of $0.7M; operating loss narrowed to $0.1M from $8.0M.
- Updated FY2021 revenue guidance: $216.3M–$224.5M (growth 16%–20%), low end raised from prior $215.3M.
- Appointed Eric Pauls as SVP of Sales effective May 1, succeeding Bryan Rishe.
- Restated credit facility with Wells Fargo: $25M revolving with $30M accordion (up to $55M), replacing $10M facility.

## SEC filing metadata
- accession: 0001558370-21-009802
- form_type: 8-K
- ticker: TCMD
- cik: 0001027838
- company_name: TACTILE SYSTEMS TECHNOLOGY INC
- filed_at: 2021-08-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1027838/000155837021009802/0001558370-21-009802-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1027838/000155837021009802/tcmd-20210802x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-21-009802
- JSON: https://secwatch.observer/filing/0001558370-21-009802.json
- Plain text: https://secwatch.observer/filing/0001558370-21-009802.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.